Screening for HIV-Associated Neurocognitive Disorders: Sensitivity and Specificity.

Reuben N Robbins1, Travis M Scott2,3, Hetta Gouse4

  • 1HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute and Columbia University Medical Center, New York, NY, USA. rnr2110@cumc.columbia.edu.

Summary

HIV-associated neurocognitive disorder (HAND) screening is recommended but not routinely performed. This review examines current HAND screening tests, highlighting challenges in detecting mild forms and their suitability for global use.